Cited by 658Nutrition and Health in AgingHeart Failure Treatment and ManagementCardiovascular and exercise physiology

Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF)

Fulster, S., Tacke, M., Sandek, A., Ebner, N., Tschope, C., Doehner, W., Anker, S. D., von Haehling, S.·2013·European Heart Journal

Abstract

AIMS: To assess the prevalence and clinical impact of reductions in the skeletal muscle mass of patients with chronic heart failure (HF). Chronic HF is accompanied by co-morbidities that influence the quality of life and outcomes. METHODS AND RESULTS: We prospectively enrolled 200 patients with chronic HF. The appendicular skeletal muscle mass of the arms and the legs combined, was assessed by dual energy X-ray absorptiometry. We analysed the muscle strength in arms and legs, and all patients underwent a 6-min walk test, a 4-m walk test, and spiroergometry testing. Muscle wasting was defined as the appendicular muscle mass 2 SD below the mean of a healthy reference group of adults aged 18-40 years, as suggested for the diagnosis of muscle wasting in healthy ageing (sarcopenia). Muscle wasting was detected in 39 (19.5%) subjects. Patients with muscle wasting had significantly lower values for handgrip and quadriceps strength as well as lower total peak oxygen consumption (peakVO2, 1173 ± 433 vs. 1622 ± 456 mL/min), lower exercise time (7.7 ± 3.8 vs. 10.22 ± 3.0 min, both P < 0.001), and lower left ventricular ejection fraction (LVEF, P = 0.05) than patients without. The distance walked during 6 min and the gait speed during the 4-m walk were lower in patients with muscle wasting (both P < 0.05). Serum levels of interleukin-6 were significantly elevated in patients with muscle wasting (P = 0.001). Logistic regression showed muscle wasting to be independently associated with reduced peak VO2 adjusted for age, sex, New York Heart Association class, haemoglobin, LVEF, distance walked in 6 minutes, and the number of co-morbidities (odds ratio 6.53, p = 0.01). CONCLUSION: Muscle wasting is a frequent co-morbidity among patients with chronic HF. Patients with muscle wasting present with reduced exercise capacity and muscle strength, and advanced disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehs381

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Metabolic disorders such as diabetes may be associated with an accelerated ageing process, and more rapid wasting is commonly seen within severe disease such as chronic kidney disease and heart failure.

    “Research has shown that metabolic disorders, such as diabetes may be associated with an accelerated ageing process, and more rapid wasting is commonly seen within severe disease such as chronic kidney disease and heart failure.[43][44][45]”

    From Changes in lean body mass with <scp>glucagon‐like peptide</scp> ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [45]

    The Discussion (page unavailable) reports more muscle wasting in the heart-failure cohort than expected from ageing alone, and cites associations between muscle wasting and impaired kidney function and type 2 diabetes. It does not say that diabetes accelerates ageing or establish a faster rate of wasting in chronic kidney disease. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS. Sarcopenia. J Lab Clin Med 2001;137:231 -243.
  2. Montano-Loza AJ, Meza-Junco J, Prado CM, Lieffers JR, Baracos VE, Bain VG, Sawyer MB. Sarcopenia Is Associated with Mortality in Patients with Cirrhosis. Clin Gastroenterol Hepatol 2012;10:166 -173.

Cited by

Sorted by citations

Authors
Fulster, S., Tacke, M., Sandek, A., Ebner, N., Tschope, C., Doehner, W., Anker, S. D., & von Haehling, S.
Affiliations
  • Stiftung Charité (DE)
  • Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Venue
European Heart Journal
Published
2012-11-23
Volume
34
Issue
7
Pages
512-519
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2106569666
Cited by
658
References
46
Citations by year
2026: 41 · 2025: 51 · 2024: 46 · 2023: 71 · 2022: 61 · 2021: 62 · 2020: 58 · 2019: 48 · 2018: 57 · 2017: 41 · 2016: 37 · 2015: 33 · 2014: 27 · 2013: 21 · 2012: 2
FWCI
17.79
Type
journal article
Language
en
Open access
closed
Locations
  • European Heart Journal (publishedVersion)
  • PubMed (publishedVersion)
  • University of Bedfordshire Repository (University of Bedfordshire) (submittedVersion)
Funders
  • European Commission (241558)
  • Deutsche Forschungsgemeinschaft (SFB-TR/19)
Topics
  • Health Sciences › Medicine › Physiology › Nutrition and Health in Aging
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Complementary and alternative medicine › Cardiovascular and exercise physiology
Keywords
muscle atrophy, chronic heart failure, sarcopenia, appendicular skeletal muscle mass, muscle strength, exercise capacity, peak oxygen uptake, interleukin-6, left ventricular ejection fraction, comorbidities, walking speed, grip strength, quadriceps strength
MeSH terms
Aged, Chronic Disease, Female, Heart Failure, Humans, Male, Muscular Dystrophies, Prospective Studies, Stroke Volume, Absorptiometry, Photon, Muscle, Skeletal, Ventricular Dysfunction, Left, Hand Strength, Quadriceps Muscle, Muscle Strength, Sarcopenia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review